Glaucoma

January 20, 2021

Published by admin_auro at January 20, 2021

Categories

Regenerative therapy for curing Glaucoma: Sildenafil increases the expression of genes that promote regeneration, promotes reprogramming of aged eye cells, increases telomerase expression, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma, via up-regulation of its target gene, 20/January/2021, 9.29 pm

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]

January 26, 2020

Published by admin_auro at January 26, 2020

Categories

Taurine-based regenerative therapy for curing Glaucoma: Taurine/2-Aminoethane-1-sulfonic acid increases the expression of genes that promote regeneration, promotes reprogramming of aged eye cells, increases telomerase expression, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma, via upregulation of its target gene, 26/January/2019, 11.46 pm

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]

January 9, 2020

Published by admin_auro at January 9, 2020

Categories

Lutin/Zeaxanthin-based regenerative therapy for curing Glaucoma: A pharmaceutical mixture encompassing Lutin & Zeaxanthin increases the expression of genes that promote regeneration, promotes reprogramming of aged eye cells, increases telomerase expression, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma, via up-regulation of its target gene, 9/January/2020, 5.51 am

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]

December 6, 2019

Published by admin_auro at December 6, 2019

Categories

Apigenin/Luteolin-based regenerative therapy for curing Glaucoma: A pharmaceutical mixture encompassing Apigenin and Luteolin increases the expression of genes that promote regeneration, promotes reprogramming of aged eye cells, increases telomerase expression, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma, via upregulation of its target gene, 6/December/2019, 5.40 am

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]